From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis. (2023)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s42003-023-04589-5
PubMed Identifier: 36928598
Publication URI: http://europepmc.org/abstract/MED/36928598
Type: Journal Article/Review
Volume: 6
Parent Publication: Communications biology
Issue: 1
ISSN: 2399-3642